Intelligent Bio Solutions (INBS) Non-Current Debt (2022 - 2024)
Intelligent Bio Solutions (INBS) recorded quarterly Non-Current Debt of $150426.0 in Q1 2024, down 34.87% quarter-over-quarter from $230969.0 in Q4 2023, and down 68.05% on a YoY basis from $470872.0 in Q2 2023.
Intelligent Bio Solutions (INBS) Non-Current Debt (2022 - 2024) Analysis & Trends
Intelligent Bio Solutions' Non-Current Debt history runs 3 years deep, the most recent figure standing at $150426.0 for Q1 2024.
- In Q1 2024, Non-Current Debt fell 68.05% year-over-year to $150426.0; the TTM figure through Mar 2024 stood at $150426.0 (down 68.05% YoY), while the FY2023 annual figure was $402862.0, changed N/A from the prior year.
- Non-Current Debt was $150426.0 for Q1 2024 at Intelligent Bio Solutions, down from $230969.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $507403.0 in Q4 2022 to a low of $150426.0 in Q1 2024.
- Historically, Non-Current Debt has averaged $344794.3 across 3 years, with a median of $354548.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Non-Current Debt plunged 54.48% in 2023, then slumped 68.05% in 2024.
- A 3-year view of Non-Current Debt shows it stood at $507403.0 in 2022, then plunged by 54.48% to $230969.0 in 2023, then slumped by 34.87% to $150426.0 in 2024.
- The last three Non-Current Debt figures came in at $150426.0 (Q1 2024), $230969.0 (Q4 2023), and $306234.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 27.88 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.81 Bn |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 150,426.00 |
| Mar 31, 2024 | 150,426.00 |
| Dec 31, 2023 | 230,969.00 |
| Dec 31, 2023 | 230,969.00 |
| Sep 30, 2023 | 306,234.00 |
| Sep 30, 2023 | 306,234.00 |
| Jun 30, 2023 | 402,862.00 |
| Jun 30, 2023 | 402,862.00 |
| Mar 31, 2023 | 470,872.00 |
| Mar 31, 2023 | 470,872.00 |
| Dec 31, 2022 | 507,403.00 |
| Dec 31, 2022 | 507,403.00 |